Related Experiment Video
Updated: Oct 7, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
[Metabolic control after discharge from the DiabetIMSS program]
José Guillermo Carrillo-Medrano1, Kenia Lizzieth Villegas-Saldívar2, Eduardo Martínez-Caldera2
1Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 55, Consulta Externa. Fresnillo, Zacatecas, México.
Revista Medica Del Instituto Mexicano Del Seguro Social
|January 10, 2022
Summary
Metabolic control remains poor for diabetic patients after completing the DiabetIMSS educational program. Most patients experienced hyperglycemia and dyslipidemia, indicating a need for improved long-term diabetes management strategies.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Diabetes Management
Background:
- Mexico faces a high prevalence of metabolic decontrol in diabetic patients.
- The Program of Attention for the Diabetic Patient (DiabetIMSS) was implemented in 2008.
- DiabetIMSS utilizes educational sessions for long-term metabolic control.
Purpose of the Study:
- To evaluate the metabolic control status of diabetic patients post-DiabetIMSS program.
- To identify the long-term effectiveness of the DiabetIMSS educational intervention.
Main Methods:
- An observational, descriptive, cross-sectional, ambispective study.
- 242 patients with Type 2 Diabetes Mellitus (DM2) and ≥1 year post-DiabetIMSS discharge.
- Non-probabilistic quota sampling and Chi-square statistical analysis.
Main Results:
- High rates of metabolic decontrol observed: 79% in ≤2 years post-discharge and 81% in >2 years.
- Predominant issues include hyperglycemia (64% and 57%) and high prevalence of dyslipidemia (65.7% and 70.6%).
- Obesity is significantly associated with dyslipidemia, hypertension, and glycemic uncontrol.
Conclusions:
- DiabetIMSS participants exhibit poor metabolic control after program completion.
- The current educational program may not ensure sustained metabolic improvements.
- Further research into enhanced or alternative diabetes management strategies is warranted.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
433
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
433
01:36Carbohydrate Metabolism
12.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.4K
01:22Diabetes Mellitus: Type 2 and Gestational
3.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
01:16Insulin: Dosing Regimen and Adverse Effects
296
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
296
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.0K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K